← Companies|DBV Technologies
DB

DBV Technologies

DBVT·NASDAQMontrouge FRFounded 2002200 employees
Micro CapbiotechPublicImmunology
Platform: Viaskin Peanut
Market Cap
$0.15B
All Drugs
2
Clinical Trials
6
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (DBVT)
Loading DBVT stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
PolarasimodDBV-9997Approved4siRNAKIF18APD-1iMGWet AMD
DBV-5518DBV-5518Phase 12Bispecific AbUSP1TROP-2 ADCCRCFL
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (6)
2025-04-22
DBV-5518 Interim
CRC
Past
2028-01-11
Polarasimod Ph3 Readout
MG
Ph3 Readout
2028-01-23
Polarasimod Ph3 Readout
Wet AMD
Ph3 Readout
2029-03-17
Polarasimod Ph3 Readout
Wet AMD
Ph3 Readout
2030-08-05
Polarasimod Ph3 Readout
MG
Ph3 Readout
2031-11-15
DBV-5518 Interim
CRC
Interim